189 related articles for article (PubMed ID: 19435790)
1. Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.
Nakaya H; Summers BD; Nicholson AC; Gotto AM; Hajjar DP; Han J
Am J Pathol; 2009 Jun; 174(6):2007-14. PubMed ID: 19435790
[TBL] [Abstract][Full Text] [Related]
2. [Roles of PPARgamma in preventing the development of atherosclerosis in LDL receptor null mice].
Nakaya H
Nihon Rinsho; 2010 Feb; 68(2):229-34. PubMed ID: 20158089
[TBL] [Abstract][Full Text] [Related]
3. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}.
Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A
Circ Res; 2010 Oct; 107(8):953-8. PubMed ID: 20798360
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I
Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice.
Game BA; He L; Jarido V; Nareika A; Jaffa AA; Lopes-Virella MF; Huang Y
Atherosclerosis; 2007 May; 192(1):85-91. PubMed ID: 16901490
[TBL] [Abstract][Full Text] [Related]
7. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Hughes TA; Stentz F; Gettys T; Smith SR
Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of pioglitazone on advanced atherosclerotic lesions.
Thorp E; Tabas I
Am J Pathol; 2009 Sep; 175(3):1348. PubMed ID: 19661438
[TBL] [Abstract][Full Text] [Related]
9. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
[TBL] [Abstract][Full Text] [Related]
10. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA
Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.
Tao H; Aakula S; Abumrad NN; Hajri T
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E68-79. PubMed ID: 19861583
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.
Kasai S; Inoue T; Yoshitomi H; Hihara T; Matsuura F; Harada H; Shinoda M; Tanaka I
J Pharmacol Sci; 2008 Sep; 108(1):40-8. PubMed ID: 18776709
[TBL] [Abstract][Full Text] [Related]
13. Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques.
He L; Game BA; Nareika A; Garvey WT; Huang Y
J Cardiovasc Pharmacol; 2006 Nov; 48(5):212-22. PubMed ID: 17110803
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.
Chu Y; Lund DD; Weiss RM; Brooks RM; Doshi H; Hajj GP; Sigmund CD; Heistad DD
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):523-32. PubMed ID: 23288158
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
Yamamoto S; Zhong J; Yancey PG; Zuo Y; Linton MF; Fazio S; Yang H; Narita I; Kon V
Atherosclerosis; 2015 Sep; 242(1):56-64. PubMed ID: 26184694
[TBL] [Abstract][Full Text] [Related]
16. Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells.
Shen Y; Yuan Z; Yin A; Liu Y; Xiao Y; Wu Y; Wang L; Liang X; Zhao Y; Tian Y; Liu W; Chen T; Kishimoto C
Atherosclerosis; 2011 Oct; 218(2):330-8. PubMed ID: 21868013
[TBL] [Abstract][Full Text] [Related]
17. The effects of oleanolic acid on atherosclerosis in different animal models.
Luo H; Liu J; Ouyang Q; Xuan C; Wang L; Li T; Liu J
Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):349-354. PubMed ID: 28338883
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand.
Niho N; Takahashi M; Shoji Y; Takeuchi Y; Matsubara S; Sugimura T; Wakabayashi K
Cancer Sci; 2003 Nov; 94(11):960-4. PubMed ID: 14611672
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
Gao H; Li H; Li W; Shen X; Di B
Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
[TBL] [Abstract][Full Text] [Related]
20. Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.
Qu A; Shah YM; Manna SK; Gonzalez FJ
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):65-73. PubMed ID: 22015658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
